A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis

NCT00559273 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

307

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Anemia, Chronic

Interventions

DRUG: Methoxy polyethylene glycol-epoetin beta
DRUG: Darbepoetin alfa

Sponsor

Hoffmann-La Roche